跳至主要内容
临床试验/JPRN-UMIN000047487
JPRN-UMIN000047487已完成未知

The effects of peptide on mental health in adults: A randomized, double-blind, placebo-controlled study - The effects of peptide on mental health in adults: A randomized, double-blind, placebo-controlled study

Matsumoto City Hospital0 个研究点目标入组 140 人开始时间: 2022年4月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Subjects who use supplements, functional foods, or drugs associated with mental health. 2) Subjects with a history of and/or current mental illness or suspicion of mental illness. 3) Subjects who are undergoing medical treatment or have a previous medical history of serious diseases. 4) Subjects who have excessive alcoholic drinks (more than 60 g/day of alcohol). 5) Subjects who have severe drug allergy or severe food allergy, and/or a previous medical history of such allergies. 6) Subjects who participated in other clinical studies within 1 month before giving informed consent to participate in this study, or are planning to participate in other studies during this study. 7) Subjects who are pregnant or lactating, or who are expected to be pregnant during the study. 8) Subjects who are judged as ineligible to participate in this study by the principal investigator based on their background, physical findings, and so on.

研究者

相似试验